论文部分内容阅读
常规放疗Ⅰ期非小细胞肺癌(NSCLC)5年生存率为15％～20％。作者报道了南斯拉夫大学肿瘤科和日本东京大学胸科研究所于1988～1993年49例用超分割放射治疗(HFRT)的Ⅰ期NSCLC,男36例,女13例。年龄51～70岁,中位63岁。KPS70分3例,80、90、100分别为10、22、14例。治疗前作胸部正侧位和断层片,胸腹部CT,脑、骨放射性核素扫描。腺癌18例,鳞癌23例,大细胞7例,未分类1例。由胸内、外科、肿瘤内科和放疗科医师参与分
The 5-year survival rate of stage I non-small cell lung cancer (NSCLC) in conventional radiotherapy is 15% to 20%. The authors reported on 49 cases of stage I NSCLC with hyperfractionated radiotherapy (HFRT) from the Department of Oncology at the University of Yugoslavia and the Institute of Thoracic Research at the University of Tokyo in Japan from 1988 to 1993. There were 36 males and 13 females. Age 51 to 70 years old, median 63 years old. KPS70 was divided into 3 cases, 80, 90, and 100 were 10, 22, and 14 cases, respectively. Before treatment, chest radiographs, chest and abdomen CT, brain and bone radionuclide scans were performed. Adenocarcinoma was found in 18 cases, squamous cell carcinoma in 23 cases, large cell in 7 cases, and unclassified in 1 case. Involved from the Department of Thoracic, Surgical, Oncology and Radiotherapy